Corporate Magazine 2012 - Boehringer Ingelheim

THE SHAREHOLDERS’PERSPECTIVEchristian boehringerchairman of the shareholders’ committeeAs the shareholder family of our company, Boehringer Ingelheim, we with selfconfidencepursue our own independent path.In doing so, our direction is marked by a basic ethical understanding that placesall our corporate activity in the service of human health.Vision – Value through InnovationThe independent path lies in consistent focus on innovations from our own researchand development. For us it is important that we always retain our curiousityabout what is truly new and convey this curiosity within our company.Improving therapeutic approaches encompasses partnerships with industrial andacademic research to expand our knowledge and our capabilities for developinginnovative medicines for patients. This gives our company a perspective expressedin our vision: Value through Innovation.6Boehringer Ingelheim annual report 2012